Aurinia Pharmaceuticals Inc. (AUPH)

Last Three Months

28-Jan-24 -- 27-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

12

0

5

+1

0

+2

0

+3

Two Year Chart

28-Apr-22 -- 27-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
07-Mar-24 4:46 PM View:	06-Mar-24 Sale ($711.09K)	Greenleaf Peter Chief Executive Officer Director		Aurinia Pharmaceuticals Inc. - AUPH	54% 987.56K to 1.52M	0	0	--	--	Show Txns Hide Txns

07-Mar-24 4:44 PM View:	06-Mar-24 Sale ($194.94K)	Miller Joseph M Chief Financial Officer		Aurinia Pharmaceuticals Inc. - AUPH	48% 334.59K to 495.93K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 4:41 PM View:	06-Mar-24 Sale ($323.37K)	Robertson Stephen P. EVP, General Counsel		Aurinia Pharmaceuticals Inc. - AUPH	44% 307.34K to 443.82K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 4:42 PM View:	06-Mar-24 Sale ($99.55K)	Habig Scott Michael Chief Commercial Officer		Aurinia Pharmaceuticals Inc. - AUPH	52% 312.72K to 474.59K	0	0	--	--	Show Txns Hide Txns

29-Feb-24 4:11 PM View:	27-Feb-24 Sale ($30.07K)	Knappertz Volker EVP, Research and Development		Aurinia Pharmaceuticals Inc. - AUPH	(9%) 349.2K to 319.13K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 4:43 PM View:	06-Mar-24 Sale ($224.06K)	Donley Matthew Maxwell EVP, Ops & Strategy		Aurinia Pharmaceuticals Inc. - AUPH	43% 408.07K to 584.07K	0	0	--	--	Show Txns Hide Txns